Subscribe to Seeking Alpha feed
https://seekingalpha.com
URL: https://seekingalpha.com
Updated: 2 hours 47 min ago

Green Dot Corporation 2025 Q3 - Results - Earnings Call Presentation

Mon, 11/10/2025 - 19:01

Calamos Global Equity Fund Q3 2025 Commentary

Mon, 11/10/2025 - 19:00

Plug Power targets $700M 2025 revenue as new CEO transition and data center push reshape outlook

Mon, 11/10/2025 - 18:52

LivePerson raises 2025 revenue guidance to $240M as Conversation Simulator gains traction

Mon, 11/10/2025 - 18:52

LivePerson, Inc. 2025 Q3 - Results - Earnings Call Presentation

Mon, 11/10/2025 - 18:52

Exxon to 'pace' low-carbon spending due to weak demand, climate policies, CEO says

Mon, 11/10/2025 - 18:50

Q3 2025 Portfolio: Focusing On Resilience, Attractive Valuation And Sound Capital Allocation

Mon, 11/10/2025 - 18:45

Armstrong World Industries Doesn't Justify An Upgrade

Mon, 11/10/2025 - 18:38

Inovio outlines mid-2026 launch for INO-3107 as BLA submission progresses

Mon, 11/10/2025 - 18:32

Outset Medical signals $115M-$120M revenue guidance revision amid sales process transformation and leadership change

Mon, 11/10/2025 - 18:32

Identiv outlines Q4 revenue target of $5.4M-$5.9M as Thailand manufacturing transition drives margin growth

Mon, 11/10/2025 - 18:32

Oil rises with end to U.S. government shutdown in sight, helped by supply disruptions

Mon, 11/10/2025 - 18:30

FS KKR Capital: Q3 Earnings Reinforces Limited Growth Potential

Mon, 11/10/2025 - 18:29

Paramount Skydance outlines $30B 2026 revenue target as company accelerates D2C and content investment

Mon, 11/10/2025 - 18:22

The London Company Large Cap Portfolio (Vs. R1000V) Q3 2025 Commentary

Mon, 11/10/2025 - 18:20

Papa John's Is Still A Buy Without A Buyout Offer

Mon, 11/10/2025 - 18:14

Laird Superfood signals full-year 15% sales growth outlook as wholesale strategy advances

Mon, 11/10/2025 - 18:12

Ascend Wellness targets 60-store network within 12 months as margin expansion continues

Mon, 11/10/2025 - 18:12

Velo3D reaffirms 2025 revenue target of $50M–$60M while advancing defense and industrial partnerships

Mon, 11/10/2025 - 18:12

Mineralys outlines NDA submission timeline and advances lorundrostat trials amid expanded clinical focus

Mon, 11/10/2025 - 18:12

Pages